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Thomas Able, MD,a and Dittmar Böckler, PhD,a Heidelberg and Munich, Germany
Objective: The two techniques for carotid endarterectomy (CEA)—conventional (C-CEA) and eversion (E-CEA)—have
different effects on blood pressure. This study compared sympathetic activity after C-CEA and E-CEA, as measured by
renin and catecholamine levels.
Methods:E-CEA (n 40) and C-CEA (n 34) were performed in 74 patients with high-grade carotid stenosis. The choice
of technique was made at the discretion of the operating surgeon. All patients received clonidine (150 g) preoperatively.
Regional anesthesia was used. The carotid sinus nerve was transected during E-CEA and preserved during C-CEA. Renin,
metanephrine, and normetanephrine levels were measured preoperatively and at 24 and 48 hours postoperatively.
Results: Compared with baseline, levels of renin, metanephrine, and normetanephrine decreased at 24 and 48 hours after
C-CEA (P< .0001). After E-CEA, however, renin and normetanephrine levels were unchanged at 24 hours, and metaneph-
rine levels were increased (P< .0001). At 48 hours, levels of renin (P .04), metanephrine (P< .0001), and normetanephrine
(P .02) were increased. Compared with C-CEA, E-CEA was associated with significantly increased sympathetic activity at 24
and 48 hours (P < .0001). Although the use of vasodilators for postoperative hypertension did not differ in the
postanesthesia care unit (E-CEA 35% vs C-CEA 18%, P  .12), vasodilator use on the ward was more frequent after
E-CEA (60% vs 32%, P  .02).
Conclusions:E-CEA appears to be associated with greater postoperative sympathetic activity and vasodilator requirements
than C-CEA, findings likely related to sacrifice of the carotid sinus nerve during E-CEA but not C-CEA. (J Vasc Surg
2012;56:324-33.)
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MPatients undergoing carotid endarterectomy (CEA) are
prone to postoperative hemodynamic instability, including
hypertension, hypotension, and bradycardia, events that
have been linked to postoperative stroke, cardiac complica-
tions, and death.1-11 These hemodynamic perturbations
may relate to an altered sensitivity of the carotid sinus
baroreceptors residing at the origin of the internal carotid
artery (ICA). Baroreceptors responding to pressure are
located at key places within the cardiovascular system and
provide the brain with information about moment-to-
moment changes in arterial blood pressure. This afferent
input controls a variety of reflex responses encompassing
autonomic and endocrine adjustments, each geared toward
maintaining cardiovascular homeostasis.12
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324Eversion CEA (E-CEA), initially reported by DeBakey13
nd later described by Etheredge,14 Kasprzak and Raithel,15
nd others,16 requires full mobilization of the carotid bifurca-
ion and most often requires transection of the longitudinal
erve fibers of the carotid sinus nerve (CSN), with the loss of
he baroreceptor reflex.17 However, disruption of the CSN
bers is less likely with conventional CEA (C-CEA) due to the
ongitudinal arteriotomy commonly performed on the ante-
ior surface of the vessels, with a less extensive dissection and
obilization of the carotid bifurcation.
We confirmed a reduction in baroreceptor sensitivity (BRS)
fter E-CEA, with a shift of the autonomic balance toward
ympathetic dominance.17 Corroborating these observations, a
urther analysis at our institution demonstrated an increase in
ostoperative blood pressure with E-CEA compared with C-
EA. C-CEA was, by contrast, associated with postoperative
ypotension and bradycardia.18 We speculated that the patho-
hysiology underlying these observations is due to differential
eurohumoral responses of the autonomic nervous system after
-CEAandC-CEA, induced by different activities of theBRS in
elation to dysfunction of the CSN. The current study was per-
ormed to further explore the pathophysiology of hemodynamic
lterations after E-CEA andC-CEA, analyzing the perioperative
uctuations of plasma renin, metanephrine, and normetaneph-
ine.
ETHODS
This prospective, nonrandomized study was performed
n 74 patients undergoing E-CEA (n 40) or C-CEA (n
c
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Volume 56, Number 2 Demirel et al 32534) ICA stenosis that was symptomatic in 28 (38%) and
asymptomatic in 46 (62%). Symptomatic stenosis was
defined as transient ischemic attack or minor stroke on
the modified Rankin Scale (mRS) of 0-2. The study
Table I. Demographics and indication for surgery of patie
endarterectomy (CEA)
Variablesa E-CEA (n
Male 34
Age, years 72 
Symptomatic stenosis 11 (28
Modified Rankin scale
0 7 (64
1 2 (18
2 2 (18
CCT positive for ischemia 3 (27
Hypertension 38 (95
Coronary artery disease 14 (35
Diabetes mellitus 12 (30
Hyperlipoproteinemia 37 (92
Alcohol use 8 (20
Nicotine use 16 (40
Body mass index, kg/m2 25.86 
ASA
1 0
2 8 (20
3 32 (80
4 0
Stenosis, % 80 (80
Contralateral stenosis 70% 3 (7.5
Contralateral occlusion 0
On antihypertensive medication 35 (88
GFR, mL/min (ref: 80)b 73 (58
Urea, mg/dL (ref: 45)b 36 (30
ASA, American Society of Anesthesiologists; CCT, cranial computed tomog
aContinuous data are shown as mean  standard deviation and median (int
bThe values for GFR and urea were non-normally distributed.
Table II. Preoperative medicationsa and baseline renin an
conventional (C) carotid endarterectomy (CEA)
Variablec E-CEA (n 
Pre-op medications
Diuretics 14 (35)
-blockers 23 (58)
ACE inhibitors 19 (48)
ARB 10 (25)
Calcium channel blockers 10 (25)
Hypoglycemics 4 (10)
Statins 33 (83)
Aspirin 37 (93)
Clopidogrel 0
Warfarin 1 (3)
Laboratory values
Renin, U/mL 20.3 (9.7-71
Metanephrine, pg/mL 45.5 (33.6-6
Normetanephrine, pg/mL 87.8 (57.7-1
ACE, Angiotensin-converting enzyme; ARB, angiotensin receptor blocker.
aFisher-Freeman-Halton exact test.
bMann-Whitney U test.
cCategoric data are shown as number (%) and continuous data as median (iexcluded patients who had experienced a severe stroke aausing major disability (mRS, 3-5) and those with prior
ontralateral carotid repair and ipsilateral restenosis. The
tudy protocol was approved by the local Ethics Com-
ittee, and written informed consent was obtained from
ndergoing eversion (E) or conventional (C) carotid
0) C-CEA (n  34) P
31 .49
72  8.5 .57
17 (50) .06
.15
8 (47)
4 (24)
5 (29)
10 (59) .03
34 (100) .5
11 (32) .99
13 (38) .47
32 (94) .99
5 (15) .76
13 (38) .99
26.73  2.88 .23
.42
0
10 (29)
24 (71)
0
90 (80-90) .01
11 (32) .008
4 (12) .04
32 (94) .44
70 (55-91) .54
36.5 (31-46) .64
scan; GFR, glomerular filtration rate.
tile range), and categoric data as number (%).
echolamine levelsb in patients undergoing eversion (E) or
C-CEA (n  34) P
11 (32) .99
23 (68) .47
23 (68) .1
5 (15) .39
7 (21) .78
7 (21) .33
30 (88) .53
28 (82) .29
2 (6) .21
0 .99
35.4 (16.9-101.6) .60
38.3 (30.3-43.8) .11
63.6 (46.6-93.7) .053
artile range).nts u
 4
9.6
)
)
)
)
)
)
)
)
)
)
)
3.31
)
)
-90)
)
)
-97)
-44)
raphyd cat
40)
.1)
0.2)
15.1)ll patients.
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August 2012326 Demirel et alPatients did not discontinue baseline antihypertensive
agents, and each medication taken was recorded. Venous
blood samples for the determination of renin, metanephrine
(O-methylated metabolite of epinephrine), and normeta-
nephrine (O-methylated metabolite of norepinephrine)
levels were collected preoperatively and at 24 hours and 48
hours after the operation. The preoperative samples were
obtained in the afternoon on the day of admission, before
evening medications were administered.
All patients were asked to rest supine for at least 20
minutes before sampling. Postoperative blood samples
were collected in the early morning before the patients
arose from bed, with the patients supine for at least 20
Table III. Operative characteristics in patients undergoing
(CEA)
Variablea E-CEA (n
Duration of surgery, minutes 82.5 (65
Clamping time, minutesc 25 (21
Primary shunting 2 (5)
Secondary shunting 3 (8)
Neurologic deficit during clamping 2 (5)
aContinuous data are shown as median (interquartile range) and categoric d
bMann-Whitney U test for comparison of non-normally distributed values.
cClamping time was defined as the period where carotid flow was interrupte
Table IV. Plasma concentrations of renin, metanephrine,
or conventional (C) carotid endarterectomy (CEA)
Variablea
E-CEA (n  40)
Pre-op Post-op 24 hours
Renin 20.3 (9.7-71.1) 22.2 (12.7-79.3) .4
Metanephrine 45.5 (33.6-60.15) 53.8 (41.5-78.2) .0
Normetanephrine 87.8  40.1 85.6  39.2 .0
aData are shown as mean  standard deviation and median (interquartile ra
bSignificance pre-CEA vs post-CEA normally distributed values by paired t-
cSignificances of differences between E-CEA and C-CEA effect.
dWilcoxon signed-rank test was used.
eFor statistical comparison of the technical influence, differences betwe
Mann-Whitney U test owing to non-normality distribution.
Table V. Plasma concentrations of renin, metanephrine, a
conventional (C) carotid endarterectomy (CEA)
Variablea
E-CEA (n  40)
Pre-op Post-op 48 hours P
Renin 20.3 (9.7-71.1) 26.4 (11.6-89) .04
Metanephrine 45.5 (33.6-60.2) 58.9 (46.9-70.7) .00
Normetanephrine 87.8  40.9 94.5  36.9 .02
aData are shown as mean  standard deviation and median (interquartile ra
bSignificance pre-CEA vs post-CEA normally distributed values by paired t-
cSignificances of differences between E-CEA and C-CEA effect.
dWilcoxon signed-rank test was used.
eFor statistical comparison of the technical influence, differences betwe
Mann-Whitney U test owing to non-normality distribution.minutes before sampling. Patients were instructed to fast, ebstain from caffeinated and decaffeinated beverages over-
ight, and not to take any medication before blood sam-
ling. After blood sampling, antihypertensive and cardiac
edications were resumed. The study excluded patients
aking phenoxybenzamine and tricyclic antidepressants be-
ause of their potential to elevate plasma normetanephrine
nd norepinephrine.19
Plasma concentrations of renin were determined with a
hemiluminescence immunoassay system (LIAISON, Dia-
orin GmbH, Dietzenbach, Germany) with reference val-
es at 2.8 to 26.7 U/mL (measurement range, 0.5-500
U/mL). Plasma concentrations of metanephrine and
ormetanephrine were determined by high-performance
rsion (E) or conventional (C) carotid endarterectomy
) C-CEA (n  34) P
) 120 (110-135) .0001b
9 (8-12) .0001b
25 (74) .0001
1 (3) .62
0 (0) .5
number (%).
only included the time to insert and remove the shunt.
normetanephrine before and 24 hours after eversion (E)
C-CEA (n  34)
PcPre-op Post-op 24 hours Pb
35.4 (16.9-101.6) 15.2 (6-43.5) .0001d .0001e
38.3 (30.3-43.8) 25 (18.2-42.1) .0001d .0001e
63.6 (46.6-93.7) 42.8 (30.2-55.1) .0001d .0001e
eoperative and postoperative values were calculated and analyzed with
ormetanephrine before and 48 hours after eversion (E) or
C-CEA (n  34)
PcPre-op Post-op 48 hours Pb
35.4 (16.4-101.6) 20.2 (8.3-70.7) .0004d .0001e
38.3 (30.3-43.8) 30.4 (19.1-42.6) .0001d .0001e
63.6 (46.6-93.7) 48.7 (31.3-61.3) .0001d .0001e
eoperative and postoperative values were calculated and analyzed witheve
 40
-108
-32)
ata asand
Pb
1d
001d
7c
nge).
test.nd n
b
d
01d
b
nge).
test.nzyme-immunoassay (Biochrom Asys Expert 96 Micro-
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Volume 56, Number 2 Demirel et al 327Fig. Extended box-and-whisker plots comparing the differences of both carotid endarterectomy (CEA) operative tech-
niques between “pre-CEA and 24 hour” and “pre-CEA and 48 hour” postoperative values of (A and B) renin, (C and D)
metanephrine, and (E and F) normetanephrine. The length of each box represents the interquartile range, defined as the
distance between the 25th and the 75th percentiles. The three horizontal lines running through the box represent themedian
(middle line) and the upper and lower bounds of the 95% confidence interval around the median (median  1.58  the
quartile range). The whiskers above each box depict 1.5 times the interquartile distance and the whiskers below each box
represent the interquartile distance 1.5, asmeasured down from the top of the box.Outside values (●) are defined as those
data points that are 1.5 to 3.0 times the interquartile distance, and far outside values () are defined as those that exceed 3
times the interquartile distance.
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August 2012328 Demirel et alplate Reader, Cambridge, UK). Reference values were90
pg/mL for metanephrine (measurement range, 19.8-3000
pg/mL) and 180 pg/mL for normetanephrine (mea-
surement range, 4.19.3-6000 pg/mL).
All postoperative antihypertensive medication deci-
sions were coordinated by the two study physicians. The
definition of postoperative hypertension or hypotension
requiring vasoactive treatment was as defined previously.18
In the postanesthesia care unit, hypertension was managed
as necessary with intravenous clonidine at a dose of 75 g.
Similarly, hypertension developing on the ward was treated
with subcutaneous clonidine (75 g) or oral nifedipine (10
mg). Hypotension with systolic blood pressure 90 mm
Hg persisting for 1 hour was managed with administra-
tion of vasopressor agents, usually norepinephrine.
Operative technique. Each patient received preopera-
tive intravenous clonidine (150 g) for sedation, analgesia,
and for its stabilizing hemodynamic effect.20 All procedures
were performed by an experienced board-certified vascular
surgeon under regional anesthesia with combined deep and
superficial cervical plexus blockade, but without injection of
an anesthetic agent into the carotid sheath or around the
CSN. The choice between E-CEA and C-CEA was made at
the discretion of the operating surgeon. There was a tendency
to favorE-CEA rather thanC-CEA in patientswhere the need
for a carotid shunt would be less likely, for instance, in asymp-
tomatic patients, noting that shunt placement can be more
technically demanding with the E-CEA.21
E-CEAwas performedwith completemobilization of the
carotid bifurcation, transection of the ICA off the carotid
bulb, and division of the CSN. C-CEA was performed
through a longitudinal arteriotomy from the carotid bifurca-
tion onto the anterolateral surface of the ICA with patch
closure of the arteriotomy (Finesse Fine, Maquet Cardiovas-
cular, Wayne, NJ), preserving the CSN. The obligatory use of
a carotid shunt was limited to symptomatic patients with
infarctionon cranial computed tomography.22 Selective shunt
placement was used in all others, guided by the development
Table VI. Plasma concentrations of renin, metanephrine,
carotid endarterectomy patients with and without shunting
Variablea
With shunting (n  25)
Pre-op Post-op
Renin
24 hours 22.1 (8.2-71.4) 13.5 (5.9-40.4)
48 hours 22.1 (8.2-71.4) 18.5 (8.1-70.7)
Metanephrine
24 hours 38.3 (29.4-45.5) 24.7 (18.2-43.2)
48 hours 38.3 (29.4-45.5) 30.2 (22.9-43.1)
Normetanephrine
24 hours 63 (49.7-93.7) 45.2 (30.8-55.8)
48 hours 63 (49.7-93.7) 49.8 (28.7-61.3)
aData are shown as median (interquartile range).
bAll significance pre-CEA and post-CEA. Values were non-normally distrib
cFor statistical comparison of differences between preoperative and postoper
done owing to non-normality of distribution.of neurologic changes during carotid cross-clamping. The seriod of carotid cross-clamping was defined as the time
ithout antegrade flow in the internal carotid artery. In pa-
ients where a shunt was used, the cross-clamp time was
efined as the period where carotid flow was interrupted and
nly included the time to insert and remove the shunt.
Statistical analysis. Statistical analyses were per-
ormed using Statsdirect 2.7.3 software (Statsdirect Ltd,
heshire, UK). The Shapiro-Wilk W test was used to test
he normality of distribution for all variables. Preoperative
nd postoperative values were compared using paired t-
ests when data were normally distributed and with the
ilcoxon signed-rank test when not. Values are expressed
s mean  standard deviation for normally distributed vari-
bles; otherwise the median and interquartile range is used.
heMann-WhitneyU test was used for non-normally distrib-
ted data comparing preoperative-to-postoperative differ-
nces between patients treatedwith E-CEA vsC-CEA and for
ifferences in the duration of operation and clamping time.
he Fisher-Freeman-Halton exact test was used for analysis
f proportions. Multiple linear regression analysis was per-
ormed to identify the most significant baseline variables
ssociated with changes in renin levels. Independent vari-
bles included the type of procedure (E-CEA or C-CEA),
he clinical presentation (asymptomatic or symptomatic),
he use of an indwelling shunt, and the duration of opera-
ion was dichotomized (0 or 1, depending on whether it
as less than or greater than the median duration) to
implify the model. Stepwise backward regression was per-
ormed, excluding the factor with the lowest regression
oefficient before proceeding to the next step. P values
ere two-sided and a difference was considered statistically
ignificant when the value was .05.
ESULTS
Patients treated with E-CEA or C-CEA had similar
emographics, cardiovascular risk factors, and indications
or operation, with the exceptions of a higher grade of
psilateral stenosis and a higher frequency of contralateral
normetanephrine before and after surgery in conventional
Without shunting (n  9)
PcPre-op Post-op Pb
04 50.4 (25.9-101.6) 24.1 (7.4-75.3) .004 .88
50.4 (25.9-101.6) 24.5 (15.2-45.1) .004 .57
2 37.8 (33.6-40.9) 25.9 (18.7-29.1) .008 .70
1 37.8 (33.6-40.9) 30.5 (17.4-33.9) .05 .36
01 71.9 (32.8-83.4) 39.4 (29.1-45.5) .04 .53
01 71.9 (32.8-83.4) 47.5 (35.8-60.5) .10 .99
nd the Wilcoxon signed-rank test was used.
alues for shunting vs nonshunting, analysis with Mann-Whitney U test wasand
Pb
.00
.02
.00
.00
.00
.00
uted atenosis or occlusion in the C-CEA group (Table I). There
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erative medications between the two groups, and baseline
renin levels were similar (Table II). Trends toward higher
baseline catecholamine levels in the E-CEA group did not
attain statistical significance.
However, the technical aspects of the operative proce-
dures differed significantly (Table III). Routine shunting
was used more frequently in the C-CEA group (74% vs 5%,
P .0001), resulting in a longer median clamp time for the
E-CEA patients (25 vs 9 minutes, P  .0001). There was
no difference in the rate of neurologic changes during
carotid cross-clamping in the E-CEA and C-CEA patients
(5% vs 0%, P  .50), nor were there differences in the
selective use of a shunt for such changes (3% vs 8%, P 
.62). The median duration of operation was significantly
longer with C-CEA (120 vs 83 minutes, P  .0001). No
perioperative cardiovascular or neurologic adverse events
occurred in either group.
Laboratory changes 24 and 48 hours after
operation. There were significant preoperative-to-post-
operative decreases in renin, metanephrine, and normeta-
nephrine in the C-CEA patients at 24 and 48 hours (Tables
IV and V, Fig). By contrast, no significant preoperative-to-
postoperative differences in renin or normetanephrine were
detected in the E-CEA group at either time, andmetaneph-
rine levels increased significantly both at 24 hours and 48
hours postoperatively in this group. Significant differences
were observed in the three markers between the E-CEA
and C-CEA groups. Compared with the E-CEA group,
there were larger preoperative-to-postoperative reductions
in renin, metanephrine, and normetanephrine in the C-
CEA group for all three markers, both 24 and 48 hours
after operation (P  .001). The postoperative normeta-
nephrine changes were not correlated with baseline levels
(r  0.18, 95% confidence interval [CI] 0.39 to 0.05;
P .12), and the use of a shunt as well as the clinical status
did not affect renin or catecholamine changes at 24 or 48
hours (Tables VI and VII).
Multivariable model. After confirming an absence of
collinearity of the variables (variance inflation factor, 1.09),
multiple linear regression analysis was performed to define
Table VII. Preoperative-to-postoperative differences of re
symptomatic and asymptomatic eversion (E) or convention
Variable
Symptomatic (n  11)
Median 95% CI
Renina 4.8 10.5 to 15.5
Metanephrinea 8.2 4.7 to 16.8
Normetanephrinea 1.2 2.9 to 5.1
Reninb 6.4 16.4 to 40.1
Metanephrineb 8.4 4.4 to 13.3
Normetanephrineb 1.1 7.1 to 16.9
CI, Confidence interval.
Wilcoxon signed-rank test: a24 hours post-op, b48 hours post-op.variables associated with the preoperative-to-postoperative rhange in renin levels. The model identified the method of
EA as the only independent factor association with a
hange in renin levels. Compared with the change in renin
fter E-CEA, the regression model predicted a significant
ecrease in renin levels after C-CEA (multiple correlation
oefficient, 0.416; 95% CI, 0.208-0.589; P  .0002). The
odel excluded symptoms, use of an indwelling shunt, and
perative duration as independent factors associated with
enin changes.
Vasoactive therapy and their effect on markers.
here were no significant differences in requirement for
asodilator therapy in the E-CEA (35%) and C-CEA
roups (18%) during their stay in the postanesthesia care
nit (P  .12). On the ward, however, an increase was
oted in the requirement for vasodilators in the E-CEA
roup (60%) compared with the C-CEA group (32%, P 
02). At the time of discharge, the use of any vasoactive
gents did not differ significantly in patients undergoing
-CEA or C-CEA (Table VIII).
Levels of renin and normetanephrine decreased signif-
cantly in C-CEA patients who required vasodilator therapy
nd those who did not at 24 hours and 48 hours after CEA
Tables IX and X). Metanephrine levels were unchanged in
-CEA patients treated with vasodilators at 24 hours but
ecreased at 48 hours in those treated with vasodilators as
ell as at 24 and 48 hours in those without vasodilators.
Postoperative renin levels in E-CEA patients who re-
uired vasodilator therapy did not change significantly at
4 or 48 hours (Tables XI and XII). In E-CEA patients who
id not receive vasodilators, however, renin levels rose at
oth 24 and 48 hours, changes that ran in the opposite
irection of the renin changes observed in the C-CEA
roup. Metanephrine levels rose in E-CEA patients, irre-
pective of whether they received vasodilators, both at 24
nd 48 hours, also in contrast to the C-CEA group.
ormetanephrine levels decreased at 24 hours in E-CEA
atients who received vasodilators and were unchanged in
-CEA patients who did not receive vasodilators.
Hypotension to90mmHg lasting1 hour occurred
n two patients in the C-CEA group (6%), and each re-
uired administration of vasopressor agents (norepineph-
metanephrine, and normetanephrine levels in
) carotid endarterectomy (CEA) patients
E-CEA
Asymptomatic (n  29)
P Median 95% CI P
.97 1.1 0.8 to 4.5 .31
.001 10.5 7.3 to 13.9 .0001
.46 1.7 0.4 to 4.6 .11
.41 2.0 0.2 to 5.7 .07
.003 13.7 9.9 to 19.0 .0001
.76 8.4 1 to 14.8 .03nin,
al (Cine). However, no differences could be shown in their
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who did not require vasopressor agents. In comparison, no
patient in the E-CEA group required a vasopressor. The use
of antihypertensive medications was similar in the two
groups at discharge (Table VIII).
DISCUSSION
In comparing the two commonly used techniques for
CEA—E-CEA and C-CEA—we observed a differential
neurohumoral effect on sympathetic nervous system activ-
ity, with an increase after E-CEA and a decrease after
C-CEA. The results corroborate the findings of previous
clinical studies demonstrating opposite effects of the two
CEA techniques on postoperative blood pressure.18 The
findings of the current study add further credence to a
decrease in BRS after E-CEA, a decrease most certainly the
result of transection of the longitudinal CSN fibers during
that procedure.17 Presumably, the longitudinal arteriot-
omy and limited mobilization of the carotid bifurcation
during C-CEA limits damage to the CSN fibers. As well, an
increase in arterial wall compliance after plaque removal
may increase BRS and thereby decrease sympathetic activity
due to diminished neurohumoral response of the central
nervous system.1 The observation of improved hemody-
namic stability in the C-CEA group provides evidence that
the metanephrine and normetanephrine laboratory find-
ings may underlie the clinical manifestations observed in
Table VII. Continued.
C
Symptomatic (n  17)
Median 95% CI P
7.9 26.5 to 0.6 .03
11 18.3 to 4.4 .008
20.25 33.6 to 10.8 .0002
2.3 11.8 to 0.9 .16
5.7 21.7 to 1.8 .02
14.7 37.0 to 6.9 .0001
Table VIII. Postoperative antihypertensive medications
at discharge in patients undergoing eversion (E) or
conventional (C) carotid endarterectomy (CEA)
Variable
E-CEA
(n  40)
No. (%)
C-CEA
(n  34)
No. (%) Pa
Diuretics 16 (40) 10 (29) .46
-blocker 26 (65) 23 (58) .64
ACE inhibitor 23 (58) 23 (68) .47
ARB 10 (25) 5 (15) .39
Calcium channel blocker 12 (30) 8 (24) .6
ACE, Angiotensin-converting enzyme; ARB, angiotensin receptor blocker.
aFreeman-Halton exact test.prior studies. tPreoperative neurologic deficits have been reported to
e an independent predictor of hypertension after CEA,9,11
n observation that might be explained by an impairment of
he central component of the baroreflex.23 Lehv et al7
howed that among patients who had an alteration in the
evel of consciousness at the time of CEA, postoperative
levation of blood pressure developed in 68% vs 28% in the
eurologically intact patients. Patients with prior contralat-
ral or ipsilateral carotid surgery might have altered baro-
eflex function from damage to the CSN and the carotid
inus baroreceptors.8 For these reasons, the current study
xcluded patients with prior severe stroke and those with
revious contralateral CEA or ipsilateral restenosis.
Clonidine and calcium channel blockers are two of the
ost frequently administeredmedications for perioperative
ypertension. Whereas calcium channel blockers are known
o preserve plasma normetanephrine andmetanephrine secre-
ion,19 some evidence suggests that clonidine may alter the
evel of these catecholamines. Clonidine decreases peripheral
orepinephrine release by stimulation of prejunctional in-
ibitory 	2 adrenoceptors and by inhibition of neural trans-
ission from brainstem areas such as the nucleus-tractus
olitarius and lateral reticular nucleus in the ventrolateral
edulla.20 A placebo-controlled study by Ellis et al24
ound that plasma normetanephrine levels were signifi-
antly lowered with clonidine administration whereas
etanephrine levels were preserved. By contrast, plasma
enin activity is usually unchanged with short-term cloni-
ine use, although renin may be reduced by up to 30% with
hronic administration.25 The observed differences in cat-
cholamine and renin response between E-CEA sub-
roups, requiring vasodilator therapy or not, support our
ypothesis that deterioration of the CSN is the main deter-
inant for different neurohumoral responses between both
echniques and presumably result from decreasing effect of
lonidine on normetanephrine and renin.
The routine preoperative administration of clonidine
ay have blunted the effect of CSN disruption and aug-
ented sympathetic activity after E-CEA.17 Clonidine is
nown to have a duration of action that is24 hours at the
50- to 300-g dosages used in this study.25 The observed
Asymptomatic (n  17)
Median 95% CI P
29.3 64.9 to 5.9 .002
7.7 20.1 to 2.7 .004
12.7 26.8 to 5.2 .005
29.3 64.9 to 5.9 .0002
7.7 20.1 to 2.7 .004
12.7 26.8 to 5.2 .005-CEAime-dependent differences in catecholamine levels after
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Volume 56, Number 2 Demirel et al 331E-CEA is consistent with the hypothesis that clonidine
dampened the sympathetic response. Normetanephrine
levels were mildly diminished andmetanephrine levels were
increased within the first 24 hours after E-CEA. At 48
hours after E-CEA, however, at a time when preoperatively
administered clonidine would have been metabolized, the
levels of normetanephrine and metanephrine were each
significantly elevated compared with the preoperative base-
line.
Baroreceptors in the systemic arteries (carotid sinus and
arch of the aorta) have been implicated in the control of
renin secretion. These receptors are active at normal blood
volume and pressure; afferent impulses tonically inhibit
brainstem centers in the medulla oblongata (nucleus trac-
tus solitarii) that control the secretion of renin from the
Table IX. Plasma concentrations of renin, metanephrine,
conventional carotid endarterectomy patients with and wit
Variablea
Vasodilator therapy (n  11)
Pre-op Post-op 24 hours
Renin 22.1 (5.7-112.6) 9.5 (1.8-43.5)
Metanephrine 43.1 (35.3-77.6) 42.1 (25.9-81.7)
Normetanephrine 64.2 (35.7-101.1) 55.8 (39.4-84.5)
aData are shown as median (interquartile range).
bSignificances pre-CEA to post-CEA. All values were non-normally distribu
cFor significances of differences between vasodilator and non-vasodilator the
with Mann-Whitney U test owing to non-normality distribution.
Table X. Plasma concentrations of renin, metanephrine, a
conventional carotid endarterectomy patients with and wit
Variablea
Vasodilator therapy (n  11)
Pre-op Post-op 24 hours
Renin 22.1 (5.7-112.6) 15 (2.3-70.7)
Metanephrine 43.1 (35.3-77.6) 36.9 (22.9-43.1)
Normetanephrine 64.2 (35.7-101.1) 42.5 (28.7-61.8)
aData are shown as median (interquartile range).
bSignificances pre-CEA to post-CEA. All values were non-normally distribu
cFor significances of differences between vasodilator and non-vasodilator the
with Mann-Whitney U test owing to non-normality distribution.
Table XI. Plasma concentrations of renin, metanephrine,
eversion carotid endarterectomy patients with and without
Variablea
Vasodilator therapy (n  24)
Pre-op Post-op 24 hours
Renin 14.6 (7.4-36.6) 14.2 (7.2-34.8)
Metanephrine 50.7 (37.4-60.2) 59.6 (44-73.5)
Normetanephrine 89.4 (64.5-121.3) 85.4 (57.7-119.7)
aData are shown as median (interquartile range).
bSignificances pre-CEA to post-CEA. All values were non-normally distribu
cFor significances of differences between vasodilator and non-vasodilator the
with Mann-Whitney U test owing to non-normality distribution.kidney.26 Triggering of baroreceptors by increased arterial pall tension leads to diminished renal sympathetic outflow,
educed activity of the renin-angiotensin-aldosterone sys-
em, and a decrease in renal renin secretion.27 Sacrifice of
he CSN during E-CEA disrupts the signaling pathway to
he medulla oblongata,17 and the resultant increase in renal
ympathetic tone leads to augmented renin secretion. Con-
ersely, the CSN remains intact after C-CEA and may
ctually become more sensitive from increased compliance
f the endarterectomized arterial wall.1 This is exactly what
e observed in the current study: renin levels rose from
aseline after E-CEA but fell after C-CEA.
The major potential limitations of the current study are
nherent in its nonrandomized design. The selection of
atients with prior stroke for C-CEA might confound the
tudy results. The tendency to favor C-CEA in patients with
ormetanephrine before and 24 hours after surgery in
required vasodilator therapy
No vasodilator therapy (n  23)
PcPre-op Post-op 24 hours Pb
30.5 (16.9-101.6) 19.6 (7.4-75.3) .0007 .77
35.7 (27.1-40.9) 20.6 (15.4-29.1) .0006 .07
62.4 (46.6-83.4) 34.9 (24.6-45.8) .0001 .001
d the Wilcoxon signed-rank test was used.
tatistical comparison of the differences values were calculated and analyzed
ormetanephrine before and 48 hours after surgery in
required vasodilator therapy
No vasodilator therapy (n  23)
PcPre-op Post-op 24 hours Pb
30.5 (16.9-101.6) 28.4 (14.1-95.1) .02 .66
35.7 (27.1-40.9) 28.5 (15.2-35.1) .007 .44
62.4 (46.6-83.4) 49.9 (31.3-61.3) .0002 .39
d the Wilcoxon signed-rank test was used.
tatistical comparison of the differences values were calculated and analyzed
ormetanephrine before and 24 hours after surgery in
ired vasodilator therapy
No vasodilator therapy (n  16)
PcPre-op Post-op 24 hours Pb
51.3 (15.7-201) 69.8 (25.2-215.5) .01 .002
01 37.1 (29.9-63.7) 49.7 (39-79.4) .0001 .44
86.2 (51-101.7) 79.8 (54.4-92.8) .74 .19
nd the Wilcoxon signed-rank test was used.
tatistical comparison of the differences values were calculated and analyzedand n
hout
Pb
.001
.12
.049
ted annd n
hout
Pb
.02
.01
.006
ted anand n
requ
Pb
.08
.00
.04
ted, arior stroke is explained by a partiality toward intraopera-
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such patients, and shunt placement is technically more
difficult with E-CEA. Related to this selection bias, another
potentially confounding issue is themore frequent use of an
indwelling shunt and shorter carotid clamp times in the
C-CEA patients. However, the multiple regression analysis
provides some evidence that selection bias was not impor-
tant in the study findings. The regression model identified
the technique of CEA as the only significant factor associ-
ated with renin changes.
Another potential study limitation is the use of antihy-
pertensive medications that might mask effects on sympa-
thetic activity that would otherwise be manifest if not for
the perioperative administration of such agents. Although
evidence shows that -blockers reduce renal sympathetic
nerve activity and renin secretion,28 the C-CEA and E-
CEA groups were equally balanced with respect to the
preoperative and postoperative use of vasoactive medica-
tions.
CONCLUSIONS
Comparison with conventional CEA, external CEA is
associated with increased sympathetic nervous system activ-
ity during the early perioperative period, an observation
most likely attributable to the transection of the CSN.
Longer-term comparative studies will be necessary to ascer-
tain whether these effects persist, and if so, to determine
any effect they might have on long-term cardiovascular
morbidity.
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